Elevance Health, Inc.
Financials
Valuation Metrics
Elevance Health, Inc.'s Market Cap is $89.83B. At end of 2025 it was $77.75B. Ranked #188 of 3,116 in US market (top 6%), #132 of 1,644 on NYSE (top 8%), #11 of 203 in Health Care Equipment & Services (top 5%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $89.83B | US#188/3,116 Sec#11/203 |
| Revenue | $201.83B | US#22/3,116 Sec#7/203 |
| Net Income | $5.14B | US#144/3,116 Sec#7/203 |
| Total Assets | $127.80B | US#141/3,116 Sec#4/203 |
| Net Assets | $44.68B | US#99/3,116 Sec#7/203 |
| Employees | 96,129 | US#118/3,116 Sec#7/203 |
| Value | ||
| P/E | 17.48x | US#973/3,116 Sec#18/203 |
| P/B | 2.01x | US#1,294/3,116 Sec#56/203 |
| P/S | 0.45x | US#289/3,116 Sec#21/203 |
| EV/EBITDA | 12.42x | US#1,193/3,116 Sec#35/203 |
| FCF Yield | 7.25% | US#968/3,116 Sec#36/203 |
| Profitability | ||
| ROE | 11.50% | US#1,199/3,116 Sec#60/203 |
| ROA | 4.02% | US#1,220/3,116 Sec#82/203 |
| Op. Margin | 3.69% | US#2,082/3,116 Sec#115/203 |
| Revenue Growth | 3.60% | US#1,898/3,116 Sec#143/203 |
| Earnings Growth | -7.12% | US#1,395/3,116 Sec#76/203 |
| Financial Health | ||
| Debt Ratio | 185.78% | US#1,712/3,116 Sec#147/203 |
| Total Debt | $30.76B | US#157/3,116 Sec#7/203 |
| FCF | $6.51B | US#129/3,116 Sec#6/203 |
| Cash | $10.35B | US#105/3,116 Sec#5/203 |
| Current Ratio | 1.47x | US#1,687/3,116 Sec#150/203 |
| Net Debt/EBITDA | 2.30x | US#1,422/3,116 Sec#89/203 |
| Dividend | ||
| Div. Yield | 1.67% | US#1,054/3,116 Sec#15/203 |
| Div. Growth | 6.45% | US#701/3,116 Sec#26/203 |
| Performance | ||
| 1Y Return | 31.09% | US#1,007/3,116 Sec#86/203 |
| 1M Return | 7.05% | US#980/3,116 Sec#101/203 |
| From 52W High | -8.21% | US#583/3,116 Sec#71/203 |
| 1Y MDD | -26.94% | US#1,077/3,116 Sec#40/203 |
| Trading | ||
| Volume | 1,587,782 shares | US#1,771/3,116 Sec#120/203 |
| Trading Value | $659M | US#363/3,116 Sec#33/203 |
| Per Share | ||
| EPS | $23.66 | US#71/3,116 Sec#8/203 |
| BPS | $205.75 | US#25/3,116 Sec#2/203 |
Company Info
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. The company also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, it provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is based in Indianapolis, Indiana.